|

Intracoronary tirofiban Clinical Trials

1 actively recruiting trial

Also known as: Aggrastat

Top Sponsors

  • Kafrelsheikh University1

Indications

  • Tirofiban1
  • Intracoronary1
  • No-Reflow1
  • STEMI1
  • Heart Disease1

Other1 trial

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.